Author Correction: PRMT1 promotes pancreatic cancer growth and predicts poor prognosis

被引：0
|
作者：
Chao Song
Tianwei Chen
Lan He
Ning Ma
Jian-ang Li
Ye-Fei Rong
Yuan Fang
Mengmeng Liu
Dong Xie
Wenhui Lou
机构：
[1] Fudan University,Department of Pancreatic Surgery, Zhongshan Hospital
[2] Chinese Academy of Sciences,Laboratory of Molecular Oncology, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences
[3] University of the Chinese Academy of Sciences,School of Life Science and Technology
[4] Shanghai Tech University,Department of Gastroenterology, Zhongshan Hospital
[5] Fudan University,undefined
来源：
Cellular Oncology | 2020年 / 43卷 / 1期
关键词：
D O I：
10.1007/s13402-019-00480-w
中图分类号：
学科分类号：
摘要：
The authors would like to correct the following panels in Figures
引用
收藏
页码：63 / 64
页数：1
相关论文
共 50 条
  • [1] PRMT1 promotes pancreatic cancer growth and predicts poor prognosis (September, 10.1007/S13402-019-00435-1, 2019)
    Song, Chao
    Chen, Tianwei
    He, Lan
    Ma, Ning
    Li, Jian-ang
    Rong, Ye-Fei
    Fang, Yuan
    Liu, Mengmeng
    Xie, Dong
    Lou, Wenhui
    CELLULAR ONCOLOGY, 2020, 43 (01) : 63 - 64
  • [2] PRMT1 promotes pancreatic cancer development and resistance to chemotherapy
    Ku, Bomin
    Eisenbarth, David
    Baek, Seonguk
    Jeong, Tae-Keun
    Kang, Ju-Gyeong
    Hwang, Daehee
    Noh, Myung-Giun
    Choi, Chan
    Choi, Sungwoo
    Seol, Taejun
    Kim, Hail
    Kim, Yun-Hee
    Woo, Sang Myung
    Kong, Sun -Young
    Lim, Dae-Sik
    CELL REPORTS MEDICINE, 2024, 5 (03)
  • [3] PRMT1 promotes pancreatic cancer development and resistance to chemotherapy
    Ku, Bomin
    Eisenbarth, David
    Lim, Dae-Sik
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [4] PRMT1 promotes the tumor suppressor function of p14ARF and is indicative for pancreatic cancer prognosis
    Repenning, Antje
    Happel, Daniela
    Bouchard, Caroline
    Meixner, Marion
    Verel-Yilmaz, Yesim
    Raifer, Hartmann
    Holembowski, Lena
    Krause, Eberhard
    Kremmer, Elisabeth
    Feederle, Regina
    Keber, Corinna U.
    Lohoff, Michael
    Slater, Emily P.
    Bartsch, Detlef K.
    Bauer, Uta-Maria
    EMBO JOURNAL, 2021, 40 (13):
  • [5] PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer
    Nguyen, Chan D. K.
    Colon-Emeric, Benjamin A.
    Murakami, Shigekazu
    Shujath, Mia N. Y.
    Yi, Chunling
    CELL REPORTS, 2024, 43 (05):
  • [6] Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients
    Bolag Altan
    Takehiko Yokobori
    Munenori Ide
    Erito Mochiki
    Yoshitaka Toyomasu
    Norimichi Kogure
    Akiharu Kimura
    Keigo Hara
    Tuya Bai
    Pinjie Bao
    Masaki Suzuki
    Kyoichi Ogata
    Takayuki Asao
    Masahiko Nishiyama
    Tetsunari Oyama
    Hiroyuki Kuwano
    Gastric Cancer, 2016, 19 : 789 - 797
  • [7] Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients
    Altan, Bolag
    Yokobori, Takehiko
    Ide, Munenori
    Mochiki, Erito
    Toyomasu, Yoshitaka
    Kogure, Norimichi
    Kimura, Akiharu
    Hara, Keigo
    Bai, Tuya
    Bao, Pinjie
    Suzuki, Masaki
    Ogata, Kyoichi
    Asao, Takayuki
    Nishiyama, Masahiko
    Oyama, Tetsunari
    Kuwano, Hiroyuki
    GASTRIC CANCER, 2016, 19 (03) : 789 - 797
  • [8] COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer
    Owusu-Ansah, Kwabena Gyabaah
    Song, Guangyuan
    Chen, Ronggao
    Edoo, Muhammad Ibrahim Alhadi
    Li, Jun
    Chen, Bingjie
    Wu, Jian
    Zhou, Lin
    Xie, Haiyang
    Jiang, Donghai
    Zheng, Shusen
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 55 (02) : 391 - 404
  • [9] Stathmin, Interacting with Nf-κB, Promotes Tumor Growth and Predicts Poor Prognosis of Pancreatic Cancer
    Lu, Y.
    Liu, C.
    Cheng, H.
    Xu, Y.
    Jiang, J.
    Xu, J.
    Long, J.
    Liu, L.
    Yu, X.
    CURRENT MOLECULAR MEDICINE, 2014, 14 (03) : 328 - 339
  • [10] NOP10 predicts poor prognosis and promotes pancreatic cancer progression
    Dou, Jin
    Hu, Weikang
    Zhang, Xiaoyu
    Jiang, Kuirong
    BMC CANCER, 2024, 24 (01)
12345